Letter

Heat waves and the elderly

Adverse drug events

BMJ 2009; 339 doi: 10.1136/bmj.b3146 (Published 4 August 2009)
Cite this as: BMJ 2009;339:b3146

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Agnès Sommet, pharmacoepidemiologist1,
  2. Anne Castot, head2,
  3. Jean-Louis Montastruc, professor and head1
  1. 1Department of Clinical Pharmacology, Unité de Pharmacoépidémiologie EA 3696, Université de Toulouse, 31000-Toulouse, France
  2. 2Département de la Surveillance du Risque, du Bon Usage et de l’Information sur les Médicaments, Agence Française de Sécurité Sanitaire des Produits de Santé, 93285-Saint-Denis Cedex, France
  1. sommet{at}cict.fr

    The exceptional heat wave in 2003 led to excess mortality, particularly in elderly people1—in France about 14 800 deaths, mainly among people over 70.2

    We evaluated adverse drug reactions reported to …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular